$50,000 of CAMECO CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Nuclear energy and uranium issues in federal legislation; U.S. nuclear enrichment policy; any policies or legislation regarding critical minerals; FY 26 Energy Appropriations bill. U.S. global energy security policy and related foreign policy matters;"
You can find more data on corporate lobbying on Quiver Quantitative.
CCJ Hedge Fund Activity
We have seen 406 institutional investors add shares of CCJ stock to their portfolio, and 435 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALLIANCEBERNSTEIN L.P. removed 7,984,574 shares (-56.8%) from their portfolio in Q2 2025, for an estimated $592,694,928
- FIL LTD added 4,882,060 shares (+56.2%) to their portfolio in Q2 2025, for an estimated $362,395,313
- ARISTOTLE CAPITAL MANAGEMENT, LLC removed 2,334,086 shares (-52.1%) from their portfolio in Q2 2025, for an estimated $173,259,203
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 2,330,245 shares (-85.6%) from their portfolio in Q2 2025, for an estimated $172,974,086
- MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. removed 2,081,400 shares (-13.9%) from their portfolio in Q2 2025, for an estimated $154,502,322
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 2,071,373 shares (+41.4%) to their portfolio in Q2 2025, for an estimated $153,758,017
- FMR LLC added 1,567,804 shares (+10.6%) to their portfolio in Q2 2025, for an estimated $116,378,090
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CCJ Analyst Ratings
Wall Street analysts have issued reports on $CCJ in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- CLSA issued a "Outperform" rating on 09/09/2025
- RBC Capital issued a "Outperform" rating on 08/01/2025
- GLJ Research issued a "Buy" rating on 06/12/2025
- Goldman Sachs issued a "Buy" rating on 06/11/2025
To track analyst ratings and price targets for CCJ, check out Quiver Quantitative's $CCJ forecast page.
CCJ Price Targets
Multiple analysts have issued price targets for $CCJ recently. We have seen 4 analysts offer price targets for $CCJ in the last 6 months, with a median target of $90.0.
Here are some recent targets:
- Max Hopkins from CLSA set a target price of $102.0 on 09/09/2025
- Andrew Wong from RBC Capital set a target price of $110.0 on 08/01/2025
- Gordon Johnson from GLJ Research set a target price of $75.27 on 06/12/2025
- Brian Lee from Goldman Sachs set a target price of $78.0 on 06/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
